Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer With Central Nervous System Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06352502
What this trial is testing

An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis

Who this might be right for
EGF-R Positive Non-Small Cell Lung CancerCNS Metastases
Tang-Du Hospital 30
Not applicableLooking for participantsNCT05378633
What this trial is testing

The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

Who this might be right for
Brain MetastasesNsclc
University Hospital Heidelberg 190
Testing effectiveness (Phase 2)Study completedNCT00080938
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Eastern Cooperative Oncology Group 26
Not applicableStudy completedNCT00305617
What this trial is testing

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
The Cleveland Clinic 10
Large-scale testing (Phase 3)Study completedNCT00048997
What this trial is testing

Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 356
Not applicableLooking for participantsNCT05033691
What this trial is testing

Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases

Who this might be right for
NSCLCEGFR Gene MutationEGF-R Positive Non-Small Cell Lung Cancer+2 more
Hadassah Medical Organization 162
Testing effectiveness (Phase 2)UnknownNCT04211090
What this trial is testing

Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC

Who this might be right for
Non-squamous Non-small-cell Lung CancerBrain Metastases
Sun Yat-sen University 45
Testing effectiveness (Phase 2)Looking for participantsNCT04899908
What this trial is testing

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Who this might be right for
Brain CancerBrain MetastasesMelanoma+13 more
Brigham and Women's Hospital 134
Testing effectiveness (Phase 2)UnknownNCT01755624
What this trial is testing

Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)

Who this might be right for
1-5 Brain Metastases From Non-Small Cell Lung Cancer
NovoCure Ltd. 18
Not applicableEnded earlyNCT06315296
What this trial is testing

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Carcinoma+2 more
Thomas Jefferson University 1
Testing effectiveness (Phase 2)WithdrawnNCT04650490
What this trial is testing

SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasesNon Small Cell Lung Cancer
Duke University
Testing effectiveness (Phase 2)Study completedNCT02038218
What this trial is testing

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

Who this might be right for
Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
DEKK-TEC, Inc. 29
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)UnknownNCT04425681
What this trial is testing

Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer

Who this might be right for
Leptomeningeal MetastasisNon-small Cell Lung CancerEGFR Activating Mutation
Second Affiliated Hospital of Nanchang University 20
Not applicableLooking for participantsNCT05689619
What this trial is testing

SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)

Who this might be right for
Brain Metastases, AdultNon Small Cell Lung CancerBreast Cancer
A.O.U. Città della Salute e della Scienza 70
Large-scale testing (Phase 3)Study completedNCT01724801
What this trial is testing

Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer

Who this might be right for
Brain MetastasisNon Small Cell Lung Cancer
Guangdong Association of Clinical Trials 176
Testing effectiveness (Phase 2)UnknownNCT05207904
What this trial is testing

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Who this might be right for
Non-Small Cell Squamous Lung CancerBrain Metastases
Sun Yat-sen University 41
Large-scale testing (Phase 3)Looking for participantsNCT05317858
What this trial is testing

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Who this might be right for
Brain TumorNon Small Cell Lung Cancer
InSightec 30
Testing effectiveness (Phase 2)Ended earlyNCT01217411
What this trial is testing

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Who this might be right for
Adult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT02681549
What this trial is testing

Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
MelanomaNon-small Cell Lung CancerBrain Metastasis
Yale University 41
Next Page